Kanai T, Hirohashi S, Noguchi M, Shimoyama Y, Shimosato Y, Noguchi S, Nishimura S, Abe O
Pathology Division, National Cancer Center Research Institute, Tokyo.
Jpn J Cancer Res. 1987 Dec;78(12):1314-8.
Four murine monoclonal antibodies (NCC-RAS-001, -004, -005, -017) reactive with ras p21 were produced by using recombinant c-Ha-ras p21 as an immunogen. Among these antibodies, NCC-RAS-004 was extremely sensitive when used in immunoblotting analysis, facilitating semiquantitative detection of c-Ha-, c-Ki- and N-ras p21 in cell and tissue lysates. In cells carrying a point-mutationally activated ras, p21 with abnormal mobility upon sodium dodecyl sulfate-polyacrylamide gel electrophoresis was clearly detected.
以重组c-Ha-ras p21作为免疫原,制备了4种与ras p21反应的鼠单克隆抗体(NCC-RAS-001、-004、-005、-017)。在这些抗体中,NCC-RAS-004用于免疫印迹分析时极为灵敏,有助于对细胞和组织裂解物中的c-Ha-、c-Ki-和N-ras p21进行半定量检测。在携带点突变激活型ras的细胞中,能清晰检测到在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳中迁移率异常的p21。